Literature DB >> 23345330

Sox4 is required for the survival of pro-B cells.

Baohua Sun1, Saradhi Mallampati, Yun Gong, Donghai Wang, Véronique Lefebvre, Xiaoping Sun.   

Abstract

The development of mature B cells from hematopoietic stem cells is a strictly orchestrated process involving multiple regulatory genes. The transcription factor Sox4 is required for this process, but its role has not been systematically studied, and the underlying mechanisms remain unknown. To determine when and how Sox4 functions in the stepwise process of B cell development, we used mice harboring conditional null alleles for Sox4 and a Cre transgene. Sox4 deletion in hematopoietic stem cells almost entirely eliminated pro-B cells in both fetal livers and adult bone marrow, resulting in a severe deficiency in later stage B cells, including circulating mature B cells. Sox4-deficient pro-B cells, particularly those expressing the stem cell factor receptor c-Kit, readily underwent apoptosis, and even more so when c-Kit activity was inhibited by imatinib. C-Kit-expressing pro-B cells showed decreased activation of the c-Kit downstream protein Src upon Sox4 deletion. Likewise, the level of the anti-apoptotic Bcl2 protein was decreased in residual pro-B cells, and its restoration using a Bcl2 transgene allowed not only partial rescue of pro-B cell survival but also B cell maturation in the absence of Sox4. Our findings indicate that Sox4 is required for the survival of pro-B cells and may functionally interact with c-Kit and Bcl2.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23345330      PMCID: PMC3578124          DOI: 10.4049/jimmunol.1202736

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  59 in total

1.  Characterization of distinct conventional and plasmacytoid dendritic cell-committed precursors in murine bone marrow.

Authors:  Jun Diao; Erin Winter; Wenhao Chen; Claude Cantin; Mark S Cattral
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

Review 2.  Transcriptional control of early B cell development.

Authors:  Meinrad Busslinger
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

3.  Frequent aberrant immunoglobulin gene rearrangements in pro-B cells revealed by a bcl-xL transgene.

Authors:  W Fang; D L Mueller; C A Pennell; J J Rivard; Y S Li; R R Hardy; M S Schlissel; T W Behrens
Journal:  Immunity       Date:  1996-03       Impact factor: 31.745

4.  Identification of the earliest B lineage stage in mouse bone marrow.

Authors:  Y S Li; R Wasserman; K Hayakawa; R R Hardy
Journal:  Immunity       Date:  1996-12       Impact factor: 31.745

5.  Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation.

Authors:  J H Wang; A Nichogiannopoulou; L Wu; L Sun; A H Sharpe; M Bigby; K Georgopoulos
Journal:  Immunity       Date:  1996-12       Impact factor: 31.745

6.  Developmental expression of the vav protooncogene.

Authors:  X R Bustelo; S D Rubin; K L Suen; D Carrasco; M Barbacid
Journal:  Cell Growth Differ       Date:  1993-04

7.  Targeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia.

Authors:  K Nakayama; K Nakayama; I Negishi; K Kuida; H Sawa; D Y Loh
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

8.  Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4.

Authors:  M W Schilham; M A Oosterwegel; P Moerer; J Ya; P A de Boer; M van de Wetering; S Verbeek; W H Lamers; A M Kruisbeek; A Cumano; H Clevers
Journal:  Nature       Date:  1996-04-25       Impact factor: 49.962

9.  Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes.

Authors:  R Merino; L Ding; D J Veis; S J Korsmeyer; G Nuñez
Journal:  EMBO J       Date:  1994-02-01       Impact factor: 11.598

10.  A subpopulation of B220+ cells in murine bone marrow does not express CD19 and contains natural killer cell progenitors.

Authors:  A Rolink; E ten Boekel; F Melchers; D T Fearon; I Krop; J Andersson
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more
  17 in total

1.  Impact of Sox11 over-expression in Ba/F3 cells.

Authors:  Martin Lord; Gustav Arvidsson; Agata M Wasik; Birger Christensson; Anthony P Wright; Alf Grandien; Birgitta Sander
Journal:  Haematologica       Date:  2018-06-28       Impact factor: 9.941

2.  Integrated genetic approaches identify the molecular mechanisms of Sox4 in early B-cell development: intricate roles for RAG1/2 and CK1ε.

Authors:  Saradhi Mallampati; Baohua Sun; Yue Lu; Haiqing Ma; Yun Gong; Donghai Wang; Ju-Seog Lee; Kevin Lin; Xiaoping Sun
Journal:  Blood       Date:  2014-04-30       Impact factor: 22.113

Review 3.  MicroRNAs as regulatory elements in immune system logic.

Authors:  Arnav Mehta; David Baltimore
Journal:  Nat Rev Immunol       Date:  2016-04-28       Impact factor: 53.106

4.  A peripheral blood transcriptomic signature predicts autoantibody development in infants at risk of type 1 diabetes.

Authors:  Ahmed M Mehdi; Emma E Hamilton-Williams; Alexandre Cristino; Anette Ziegler; Ezio Bonifacio; Kim-Anh Le Cao; Mark Harris; Ranjeny Thomas
Journal:  JCI Insight       Date:  2018-03-08

5.  Sox4 Promotes Atoh1-Independent Intestinal Secretory Differentiation Toward Tuft and Enteroendocrine Fates.

Authors:  Adam D Gracz; Leigh Ann Samsa; Matthew J Fordham; Danny C Trotier; Bailey Zwarycz; Yuan-Hung Lo; Katherine Bao; Joshua Starmer; Jesse R Raab; Noah F Shroyer; R Lee Reinhardt; Scott T Magness
Journal:  Gastroenterology       Date:  2018-07-25       Impact factor: 22.682

6.  SOXC Transcription Factors Induce Cartilage Growth Plate Formation in Mouse Embryos by Promoting Noncanonical WNT Signaling.

Authors:  Kenji Kato; Pallavi Bhattaram; Alfredo Penzo-Méndez; Abhilash Gadi; Véronique Lefebvre
Journal:  J Bone Miner Res       Date:  2015-05-21       Impact factor: 6.741

7.  The Sox4/Tcf7l1 axis promotes progression of BCR-ABL-positive acute lymphoblastic leukemia.

Authors:  Haiqing Ma; Saradhi Mallampati; Yue Lu; Baohua Sun; Enze Wang; Xiaohong Leng; Yun Gong; Haifa Shen; C Cameron Yin; Dan Jones; Hesham M Amin; M James You; Patrick Zweidler-McKay; Yupo Ma; Hagop M Kantarjian; Ralph B Arlinghaus; Armand Glassman; Xiaoping Sun
Journal:  Haematologica       Date:  2014-07-04       Impact factor: 9.941

8.  A Mouse Model of Targeted Musashi1 Expression in Whole Intestinal Epithelium Suggests Regulatory Roles in Cell Cycle and Stemness.

Authors:  F M Cambuli; B R Correa; A Rezza; S C Burns; M Qiao; P J Uren; E Kress; A Boussouar; P A F Galante; L O F Penalva; M Plateroti
Journal:  Stem Cells       Date:  2015-09-26       Impact factor: 6.277

Review 9.  SOXC Genes and the Control of Skeletogenesis.

Authors:  Véronique Lefebvre; Pallavi Bhattaram
Journal:  Curr Osteoporos Rep       Date:  2016-02       Impact factor: 5.096

10.  Co-evolution of tumor and immune cells during progression of multiple myeloma.

Authors:  Ruiyang Liu; Qingsong Gao; Steven M Foltz; Jared S Fowles; Lijun Yao; Julia Tianjiao Wang; Song Cao; Hua Sun; Michael C Wendl; Sunantha Sethuraman; Amila Weerasinghe; Michael P Rettig; Erik P Storrs; Christopher J Yoon; Matthew A Wyczalkowski; Joshua F McMichael; Daniel R Kohnen; Justin King; Scott R Goldsmith; Julie O'Neal; Robert S Fulton; Catrina C Fronick; Timothy J Ley; Reyka G Jayasinghe; Mark A Fiala; Stephen T Oh; John F DiPersio; Ravi Vij; Li Ding
Journal:  Nat Commun       Date:  2021-05-07       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.